Das Bezirkskrankenhaus Günzburg ist ein Krankenhaus mit den Schwerpunkten Psychiatrie und Neurologie in der großen Kreisstadt Günzburg. Träger sind die Bezirkskliniken Schwaben.

During the past decade, Bezirkskrankenhaus Günzburg conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bezirkskrankenhaus Günzburg" #1 sponsor was "Genentech, Inc." with 3 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Imperial College London" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "University of Leipzig" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bezirkskrankenhaus Günzburg" #1 collaborator was "Aalborg University" with 1 trials as a collaborator, "Alfried Krupp Krankenhaus" with 1 trials as a collaborator, "Azienda Ospedaliera di Perugia" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "East Kent Hospitals University NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Bezirkskrankenhaus Günzburg" are "Alzheimer's Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Cervical Dystonia" (1 trials), "Intracerebral Hemorrhage" (1 trials) and "Ischemic Stroke" (1 trials). Many other conditions were trialed in "Bezirkskrankenhaus Günzburg" in a lesser frequency.

Most popular intervention types in "Bezirkskrankenhaus Günzburg" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "7-day Holter ECG" (1 trials), "ASA 100 mg" (1 trials), "Apixaban Oral Tablet" (1 trials), "Botulinum toxin type A" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bezirkskrankenhaus Günzburg" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Bezirkskrankenhaus Günzburg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Bezirkskrankenhaus Günzburg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bezirkskrankenhaus Günzburg, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".